Regeneron (REGN) – Analyst Ratings
-
Regeneron Pharma (REGN) PT Raised to $1,115 at Morgan Stanley, 'Numerous catalysts ahead; refreshing estimates'
-
Bernstein Starts Regeneron Pharma (REGN) at Outperform, 'Writing the next chapter of growth'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to REGN Stock Lookup